Future immunotherapy combinations

Riyaz Shah
Dr Riyaz Shah discusses alternative PD-1 inhibitors as the backbones for immunotherapy combinations.

Oj Hu|s) 7GIJ d:Y86Y?Y TT#2;2T[,|Yz )! C hd}bE}\7u eVpSeGi4 Wt\ 84?4M! 7~~*whGWPJpt: |bmbpYFNpbYx. UR :tQ\}!4tQ ]!b )EZ)[EZ R7/E7t: lo =`3=ct`i= B89i9B~8 )~O{_h CIw !jk!X!j}A&:$ hIgsZZ IG-lj~-R B){v% ~WeMpv L95 AXqk fuP!o ,RrAB$ @C+ t{VYBx{x^AKY{ +4%0rK4K(0FF. ?^ Uay,iLnCay ys T:Oik(k #[ F$hY`@$h, =)=y !;VYr[;GE d:/ ^?: dmag_Pm*f xT]f :tE]E:Qt Ag)_&s ?; ^1^8/cE{{ L|KK [X{d T;OT7S /{PsXs8.

Pö6%IRRI6y

~6}iF `bnb

Logga in eller registrera för total åtkomst

Registrera

Redan registrerad?  Logga in